Skip to content
10-Q

Quarterly Report

THERALINK TECHNOLOGIES, INC.

0001493152-24-007204

← back to feed
Filed
Feb 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Feb 20, 2024 6.15B sh
Shares Diluted Q1 2024 · Dec 31, 2023 6.15B sh
Shares Diluted Q1 2024 · Dec 31, 2022 6.15B sh
Operating Cash Flow Q1 2024 · Dec 31, 2023 −$962.79K
Operating Cash Flow Q1 2024 · Dec 31, 2022 −$1.78M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$57.12M
Stockholders Equity Q1 2024 · Sep 30, 2023 −$38.12M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$44.3M
Stockholders Equity Q1 2024 · Sep 30, 2022 −$6.8M
Current Liabilities Q1 2024 · Dec 31, 2023 $57.79M
Current Liabilities Q1 2024 · Sep 30, 2023 $39.83M
Total Liabilities Q1 2024 · Dec 31, 2023 $58.9M
Total Liabilities Q1 2024 · Sep 30, 2023 $40.97M
Current Assets Q1 2024 · Dec 31, 2023 $256.67K
Current Assets Q1 2024 · Sep 30, 2023 $1.26M
Total Assets Q1 2024 · Dec 31, 2023 $1.78M
Total Assets Q1 2024 · Sep 30, 2023 $2.85M
Eps Diluted Q1 2024 · Dec 31, 2023 $0.00
Eps Diluted Q1 2024 · Dec 31, 2022 −$0.01
Eps Basic Q1 2024 · Dec 31, 2023 $0.00
Eps Basic Q1 2024 · Dec 31, 2022 −$0.01
Sga Expense Q1 2024 · Dec 31, 2023 $0
Sga Expense Q1 2024 · Dec 31, 2022 $0
Net Income Q1 2024 · Dec 31, 2023 −$19.05M
Net Income Q1 2024 · Dec 31, 2022 −$36.46M
Operating Income Q1 2024 · Dec 31, 2023 −$1.55M
Operating Income Q1 2024 · Dec 31, 2022 −$2.58M
Gross Profit Q1 2024 · Dec 31, 2023 $31K
Gross Profit Q1 2024 · Dec 31, 2022 $44.48K
Cost Of Revenue Q1 2024 · Dec 31, 2023 $52.95K
Cost Of Revenue Q1 2024 · Dec 31, 2022 $10.82K
Revenue Q1 2024 · Dec 31, 2023 $83.95K
Revenue Q1 2024 · Dec 31, 2022 $55.3K
Capex Q1 2024 · Dec 31, 2022 $7.98K